Tag: opioid

59 posts found

Opioid Developments

Johnson & Johnson to Pay $572 Million in Opioid Trial

An Oklahoma judge found the drug maker to be partially responsible for the harm of the opioid epidemic.

Opioid Developments

WCRI Reports on Interstate Variation in Dispensing Opioids

While many states report fewer opioid prescriptions, MME levels vary more significantly by state.

Medmonitor

First-Time Generics Approved for Two Pain Medications

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.

Clinical Insights

NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Medmonitor

FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.

Opioid Developments

FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

Medmonitor

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

Clinical Insights

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

Opioid Developments

National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

Medmonitor

FDA Tightens Restrictions for Transmucosal Fentanyl Products

New changes to REMS safety programs will require stronger treatment documentation and oversight.

Clinical Insights

The Impact of the Changing Workforce

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

Opioid Developments

Oklahoma Reaches $270 Million Settlement with Opioid Manufacturer

Various state and local governments have sued drug developers for the harms of the opioid epidemic, and this could be the first of many settlements.

This Month's Must Read

Opioid Imbalance: Risk Disparities Among Diverse Patient Populations

Demographic factors such as gender, ethnicity, socioeconomic status, age, and location can impact opioid risks.

This Month's Must Read

Marijuana – What to Expect in 2019 and Beyond

Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.

Opioid Marketing Tied to Higher Prescribing and Overdose

A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.

Prev 1 2 3 4 Next